144
pts
FDA intends to take action against non-FDA-approved GLP-1 drugs
AI Summary
The FDA plans to take action against non-FDA-approved GLP-1 drugs, which are used for weight management and diabetes treatment. This decision aims to ensure safety and efficacy by regulating the availability of these medications to the public.